Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Furrer

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Sexually Transmitted Infections|January 22, 2009
Assessment of a real-time PCR test to diagnose syphilis from diverse biological samplesA Gayet-Ageron, B Ninet, L Toutous-Trellu, et al.
HIV Medicine|May 23, 2009
How reliable is an undetectable viral load?Christophe Combescure, N Vallier, B Ledergerber, et al.
HIV Medicine|May 12, 2015
Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapyA C Achhra, A Phillips, S Emery, et al.
AIDS (London, England)|October 2, 2001
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort StudyA C Friedl, B Ledergerber, M Flepp, et al.
HIV Medicine|June 4, 2009
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort StudyR Weber, M Huber, M Rickenbach, et al.
HIV Medicine|May 10, 2014
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort StudyJ Schäfer, J Young, E Bernasconi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2006
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapyS Bertschy, M Opravil, M Cavassini, et al.
AIDS (London, England)|March 15, 2000
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort StudyS Yerly, L Kaiser, T V Perneger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort StudyS Bassetti, M Battegay, H Furrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1995
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virusM Opravil, M Pechère, A Lazzarin, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Sexually Transmitted Infections|January 22, 2009
Assessment of a real-time PCR test to diagnose syphilis from diverse biological samplesA Gayet-Ageron, B Ninet, L Toutous-Trellu, et al.
HIV Medicine|May 23, 2009
How reliable is an undetectable viral load?Christophe Combescure, N Vallier, B Ledergerber, et al.
HIV Medicine|May 12, 2015
Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapyA C Achhra, A Phillips, S Emery, et al.
AIDS (London, England)|October 2, 2001
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort StudyA C Friedl, B Ledergerber, M Flepp, et al.
HIV Medicine|June 4, 2009
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort StudyR Weber, M Huber, M Rickenbach, et al.
HIV Medicine|May 10, 2014
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort StudyJ Schäfer, J Young, E Bernasconi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2006
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapyS Bertschy, M Opravil, M Cavassini, et al.
AIDS (London, England)|March 15, 2000
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort StudyS Yerly, L Kaiser, T V Perneger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort StudyS Bassetti, M Battegay, H Furrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1995
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virusM Opravil, M Pechère, A Lazzarin, et al.
Pageof 10